Pediatric Oncology Trials Should Start After Adult Phase I Data – Subcmte.
Executive Summary
Pediatric oncology trials usually should be initiated after collection of data from Phase I adult trials, FDA's Pediatric Subcommittee of the Oncologic Drugs Advisory Committee recommended Oct. 17